BR0208475A - Solução para administração intravenosa, e, método para a produção de uma solução de amiodarona adequada para administração intravenosa - Google Patents
Solução para administração intravenosa, e, método para a produção de uma solução de amiodarona adequada para administração intravenosaInfo
- Publication number
- BR0208475A BR0208475A BR0208475-9A BR0208475A BR0208475A BR 0208475 A BR0208475 A BR 0208475A BR 0208475 A BR0208475 A BR 0208475A BR 0208475 A BR0208475 A BR 0208475A
- Authority
- BR
- Brazil
- Prior art keywords
- solution
- intravenous administration
- amiodarone
- producing
- administration
- Prior art date
Links
- 238000001990 intravenous administration Methods 0.000 title abstract 5
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 title abstract 4
- 229960005260 amiodarone Drugs 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000000243 solution Substances 0.000 abstract 7
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 238000010790 dilution Methods 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 239000002357 osmotic agent Substances 0.000 abstract 1
- 239000003182 parenteral nutrition solution Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008215 water for injection Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Abstract
"SOLUçãO PARA ADMINISTRAçãO INTRAVENOSA, E, MéTODO PARA A PRODUçãO DE UMA SOLUçãO DE AMIODARONA ADEQUADA PARA ADMIMSTRAçãO INTRAVENOSA". é apresentada uma solução parenteral pré-misturada para administração intravenosa, tendo amiodarona, como um ingrediente ativo, solubilizada em uma solução de água para injeção e cerca de 0,4 a 12 mg/ml de tensoativo não iónico em uma faixa de concentração de 0,2 a 6 mg/ml. Uma solução opcionalmente pode incluir um agente osmótico. Nenhuma diluição da solução é necessária antes da administração a um paciente e a solução embalada estéril tem um pH inicial dentro da faixa de cerca de 2,9 a cerca de 3,2, preferivelmente de cerca de 3,1. Adicionalmente, um método para produzir uma solução de amiodarona adequada para a administração intravenosa é ainda apresentado.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/822,767 US20020143051A1 (en) | 2001-03-29 | 2001-03-29 | Premixed amiodarone parenteral solution and method for making the same |
| US09/945,374 US7067143B2 (en) | 2001-03-29 | 2001-08-31 | Premixed amiodarone parenteral solution and method for making the same |
| PCT/US2002/010094 WO2002078605A2 (en) | 2001-03-29 | 2002-03-28 | Premixed amiodarone parenteral solution and method for making the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0208475A true BR0208475A (pt) | 2004-03-09 |
Family
ID=27124676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0208475-9A BR0208475A (pt) | 2001-03-29 | 2002-03-28 | Solução para administração intravenosa, e, método para a produção de uma solução de amiodarona adequada para administração intravenosa |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1372637B1 (pt) |
| JP (1) | JP2004528315A (pt) |
| CN (1) | CN100512810C (pt) |
| AT (1) | ATE386512T1 (pt) |
| BR (1) | BR0208475A (pt) |
| CA (1) | CA2442365A1 (pt) |
| HU (1) | HUP0304086A3 (pt) |
| MX (1) | MXPA03008857A (pt) |
| RU (1) | RU2003131686A (pt) |
| WO (1) | WO2002078605A2 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110077673A1 (en) * | 2009-09-29 | 2011-03-31 | Cardiovascular Systems, Inc. | Rotational atherectomy device with frictional clutch having magnetic normal force |
| US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
| CN110261508B (zh) * | 2019-07-05 | 2022-03-11 | 合肥拓锐生物科技有限公司 | 一种盐酸胺碘酮原料药中有关物质的分析方法 |
| CN110672734B (zh) * | 2019-08-28 | 2022-03-11 | 合肥拓锐生物科技有限公司 | 一种盐酸胺碘酮注射液中有关物质的分析方法 |
| CN112472668B (zh) * | 2020-10-29 | 2023-02-28 | 太阳升(亳州)生物医药科技有限公司 | 用于制备盐酸胺碘酮注射液的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234949A (en) * | 1992-04-01 | 1993-08-10 | Academic Pharmaceuticals, Inc. | Parenteral solutions containing amiodarone in acetate buffer solution |
| FR2735978B1 (fr) * | 1995-06-30 | 1997-09-19 | Sanofi Sa | Composition pharmaceutique d'amiodarone pour administration parenterale |
| US6479541B1 (en) * | 2000-03-30 | 2002-11-12 | Baxter International | Amiodarone-containing parenteral administration |
-
2002
- 2002-03-28 AT AT02736532T patent/ATE386512T1/de not_active IP Right Cessation
- 2002-03-28 RU RU2003131686/15A patent/RU2003131686A/ru not_active Application Discontinuation
- 2002-03-28 CA CA002442365A patent/CA2442365A1/en not_active Abandoned
- 2002-03-28 BR BR0208475-9A patent/BR0208475A/pt not_active Application Discontinuation
- 2002-03-28 CN CNB028075250A patent/CN100512810C/zh not_active Expired - Fee Related
- 2002-03-28 HU HU0304086A patent/HUP0304086A3/hu unknown
- 2002-03-28 JP JP2002576874A patent/JP2004528315A/ja active Pending
- 2002-03-28 EP EP02736532A patent/EP1372637B1/en not_active Expired - Lifetime
- 2002-03-28 MX MXPA03008857A patent/MXPA03008857A/es unknown
- 2002-03-28 WO PCT/US2002/010094 patent/WO2002078605A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03008857A (es) | 2004-05-24 |
| HUP0304086A2 (hu) | 2004-04-28 |
| CN100512810C (zh) | 2009-07-15 |
| EP1372637A2 (en) | 2004-01-02 |
| JP2004528315A (ja) | 2004-09-16 |
| CN1531427A (zh) | 2004-09-22 |
| WO2002078605A3 (en) | 2003-02-06 |
| WO2002078605A2 (en) | 2002-10-10 |
| CA2442365A1 (en) | 2002-10-10 |
| RU2003131686A (ru) | 2005-01-27 |
| ATE386512T1 (de) | 2008-03-15 |
| EP1372637B1 (en) | 2008-02-20 |
| HUP0304086A3 (en) | 2005-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0515573A (pt) | copolìmero por blocos, preparação de micela e agente anticáncer contendo a mesma como o ingrediente ativo | |
| BR0315700A (pt) | Dispositivo médico implantável que incorpora rapamicina deuterada para a aplicação controlada da mesma | |
| MXPA02006758A (es) | Composicion de prostaglandinas y metodos de tratamiento de la disfuncion erectil masculina. | |
| WO2000015233A1 (en) | Compositions for the treatment of male erectile dysfunction | |
| BR9702362A (pt) | Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação. | |
| DE60220408D1 (de) | Sequenzielles arzneimittelabgabesystem | |
| DOP2000000114A (es) | Oxazolidinonas substituidas y su uso | |
| ATE495748T1 (de) | Parasiticide formulierung und methode zur herstellung dieser formulierung | |
| CO5650245A2 (es) | Formulaciones dispersable de un agente anti-inflamatorio | |
| ECSP055938A (es) | Formulaciones farmaceuticas liquidas de palonosetron | |
| US5756552A (en) | Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation | |
| DE69619673D1 (de) | Parenteral anzuwendende arzneizubereitung enthaltend amiodaron | |
| BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
| WO1998052612A1 (fr) | Composition antiseptique | |
| ES2785999T3 (es) | Composición para su uso en la preparación de un paciente para cirugía | |
| RU2002123180A (ru) | Анестезирующие рецептуры | |
| ES2125696T3 (es) | Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales. | |
| BR0116060A (pt) | Composição farmacêutica de dronedarona para administração parenteral | |
| BR0208475A (pt) | Solução para administração intravenosa, e, método para a produção de uma solução de amiodarona adequada para administração intravenosa | |
| JP2006504771A (ja) | システインを伴うプロポフォール | |
| ES2186207T3 (es) | Metodo para preparacion de formulaciones farmaceuticas. | |
| CZ300213B6 (cs) | Farmaceutická kompozice ve forme ocních kapek, zpusob její prípravy a použití azithromycinu | |
| CO5540279A2 (es) | Formulacion liofilitada de 2-metil-tieno-benzodiazepina | |
| KR100332615B1 (ko) | 구강용겔조성물 | |
| CA2179147A1 (en) | Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |